Back to Search Start Over

Carbon dots as nanocatalytic medicine for anti-inflammation therapy.

Authors :
Kong, Bo
Yang, Tong
Cheng, Feng
Qian, Yan
Li, Chunmei
Zhan, Lei
Li, Yuanfang
Zou, Hongyan
Huang, Chengzhi
Source :
Journal of Colloid & Interface Science. Apr2022, Vol. 611, p545-553. 9p.
Publication Year :
2022

Abstract

Metal free carbon dots (CDs) are developed to act as the antioxidant multienzyme, which directly deplete the excessive ROS including H 2 O 2 , O 2 −, and OH and effectively alleviate the inflammation of inflamed liver tissues through intrinsic passive targeting capability, endowing them with a high promise in nanocatalytic medicine for anti-inflammation therapy. [Display omitted] Aberrant reactive oxygen species (ROS) generation is one of the crucial mediators in the pathogenesis of inflammation. So, the development of nanocatalytic medicine to catalyze the ROS-scavenging reactions in pathological regions are promising for anti-inflammatory therapy. Herein, a type of biocompatible metal free carbon dots is prepared via a hydrothermal method which can exhibit peroxidase (POD)-like, catalase (CAT)-like and superoxide dismutase (SOD)-like activities. It has been found that the carbon dots have the capability to efficiently deplete the excessive ROS such as peroxide (H 2 O 2) , superoxide anion (O 2 −) and hydroxyl radical (OH) for their abundant functional groups. After the tail injection in mice with liver inflammation induced by lipopolysaccharide, the carbon dots efficiently reduced the excessive production of ROS and proinflammatory cytokines in vitro. Both in vitro and in vivo results endowed the biocompatible carbon dots with great potential in nanocatalytic medicine for the treatment of disease. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00219797
Volume :
611
Database :
Academic Search Index
Journal :
Journal of Colloid & Interface Science
Publication Type :
Academic Journal
Accession number :
154693659
Full Text :
https://doi.org/10.1016/j.jcis.2021.12.107